Health

RSV: Jab for winter virus could cut baby hospitalisations by 80%, study says


Prof Saul Faust, co-study leader at the University of Southampton and a consultant paediatrician, said: “These latest results show that this long-acting antibody is safe and could protect thousands of babies from hospitalisation when used in conditions similar to routine clinical practice. It is really important information for the UK to help decide on options for the future national RSV immunisation programme.”



READ SOURCE

Readers Also Like:  Consider statins for millions more people in England, NHS told

This website uses cookies. By continuing to use this site, you accept our use of cookies.